Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07197957 · ClinicalTrials.gov registry record
Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
A clinical trial of Acute Kidney Injury, sponsored by BayCare Health System.
- Recruiting
- Registry status
- 100
- Enrollment target
- 4
- Study locations
NCT07197957: Recruiting study of Acute Kidney Injury, sponsored by BayCare Health System.
NCT07197957 is a study of Acute Kidney Injury that is actively recruiting participants, run by BayCare Health System. The registered enrollment target is 100 participants, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07197957, a study of Acute Kidney Injury, is actively recruiting participants, sponsored by BayCare Health System.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Conditions Studied
Study Locations (4)
Florida
- Morton Plant Hospital - Clearwater
- Morton Plant North Bay Hospital - New Port Richey
- Mease Countryside Hospital - Safety Harbor
- St. Anthony's Hospital - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2027-02-28 |
What NCT07197957 shows while recruiting
NCT07197957 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 0 interventions.
NCT07197957 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07197957 about?
NCT07197957 is a clinical study titled "Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury". To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
What is the current status of trial NCT07197957?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-03-11. Estimated completion is 2027-02-28.
What conditions does trial NCT07197957 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
Who is sponsoring clinical trial NCT07197957?
This trial is sponsored by BayCare Health System, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07197957 being conducted?
This trial has 4 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07197957's enrollment target sits among peer trials
100 44th of 74 higher than 28 of 74 other Acute Kidney Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Kidney Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI